Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

Biotechnology

Health Care

Health Diagnostics

Medical Devices

Pulmocide

Pulmocide's headquarters in London, United Kingdom

Dan Burgess

Matt Dallas

Ashish Sagrolikar

David Mantus

Jennifer Giottonini Cayer

Pete Strong

Anne Brindley

Lance Berman

Kate Bingham

Sabine Dandiguian

Matthew Foy

Fiona MacLaughlin

Jim Meyers

Sam Williams

Kabeer Aziz

Alex Pasteur

The Directors at Pulmocide are responsible for setting the strategic vision, guiding research and development, securing funding, and overseeing regulatory compliance to advance the company's mission of developing inhaled treatments for respiratory viral and fungal infections.

Directors

This department oversees clinical development, regulatory compliance, and strategic guidance for medical products.

Clinical and Regulatory Affairs

The Leadership Team at Pulmocide spearheads strategic initiatives and makes high-level decisions to drive the company's mission of developing inhaled medicines for respiratory viral and fungal infections. They oversee scientific research, business development, regulatory compliance, clinical trials, and commercial strategy to ensure organizational growth and success.

Leadership Team

This department oversees strategic direction and governance in medical and scientific initiatives.

Medical and Scientific Leadership

Pulmocide

Org chart

Board & advisors

Teams

Directors

Clinical and Regulatory Affairs

Leadership Team

Medical and Scientific Leadership

Offices

Pulmocide

Org chart

Board & advisors

Teams

Directors

Clinical and Regulatory Affairs

Leadership Team

Medical and Scientific Leadership

Offices

Related companies